Investor Relations Consulting Agreement Between Entest BioMedical Inc. And Synergy Business Consultants LLCEntest Biomedical, Inc. • April 3rd, 2017 • Pharmaceutical preparations • California
Company FiledApril 3rd, 2017 Industry JurisdictionThis document acts forth the agreement Entest BioMedical Inc. (“the Company”) and Synergy Business Consultants LLC concerning Investor Relation and Financial Public Relation services rendered to the Company from January 30, 2017 and continuing through February 30, 2017. (1 month).
ENTEST BIOMEDICAL,INC AND THOMAS E. ICHIM AGREEMENTEntest Biomedical, Inc. • April 3rd, 2017 • Pharmaceutical preparations
Company FiledApril 3rd, 2017 IndustryEntest Biomedical, Inc. agrees to purchase Regen BioPharma Inc.’s certificate #RA 576 for 3,500,000 series A preferred shares from Thomas E. Ichim ( owner) for the price of $5,000 cash and 500,000 Entest Biomedical, Inc. series B preferred shares.